Today: 24 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

ServiceNow stock slips in year-end trade as thin volumes hit growth names — what to watch next

ServiceNow stock slips in year-end trade as thin volumes hit growth names — what to watch next

ServiceNow shares fell 0.3% to $153.81 in thin afternoon trading Wednesday, tracking a broader tech pullback as year-end liquidity dried up. The move followed a 5-for-1 stock split and news of a $7.75 billion deal to acquire cybersecurity firm Armis. Investors are also weighing a CEO contract amendment effective Jan. 1. About 2.8 million shares traded in a narrow range.
31 December 2025
··
Visa stock slips as escrow-linked share conversion update hits year-end trade

Visa stock slips as escrow-linked share conversion update hits year-end trade

Visa shares slipped 0.3% to $352.48 Wednesday after the company updated conversion rates for legacy class B shares following a $500 million deposit into its U.S. litigation escrow account. The new rates, effective Dec. 23, lower the conversion ratios for class B-1 and B-2 shares. Mastercard, American Express, and PayPal also traded slightly lower. Investors await Visa’s quarterly results on Jan. 27.
31 December 2025
·
Goldman Sachs stock slips on New Year’s Eve as Fed repo borrowing hits a record

Goldman Sachs stock slips on New Year’s Eve as Fed repo borrowing hits a record

Goldman Sachs shares fell 0.3% to $881.64 in thin year-end trading Wednesday. The New York Fed’s repo facility saw record borrowing at $74.6 billion, underscoring strong demand for cash. Wall Street’s main indexes edged lower, with the Dow down 0.19% and the S&P 500 off 0.15%. Investors are watching for Goldman’s Jan. 15 earnings and the Fed’s Jan. 27-28 meeting.
31 December 2025
··
Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

Exxon Mobil shares slipped 0.6% to $120.22 in afternoon trading Wednesday as oil prices hovered near $61 a barrel for Brent and $58 for WTI. U.S. crude inventories fell by 1.9 million barrels last week, but gasoline and distillate stocks rose sharply. Investors are watching the Jan. 4 OPEC+ meeting and late-January earnings for direction. Other oil majors were mixed to lower.
31 December 2025
··
AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

AppLovin (NASDAQ: APP) stock dips today as year-end tech pullback pressures growth names

AppLovin shares fell 1.3% to $685 in thin year-end trading Wednesday, underperforming major indexes as investors rotated out of high-growth tech stocks. Treasury yields rose after jobless claims dropped to 199,000, pressuring growth shares further. The Invesco QQQ Trust and S&P 500-tracking SPDR fund each slipped about 0.2% in afternoon trading.
31 December 2025
···
Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

Applied Digital (APLD) climbs on fresh analyst calls as ChronoScale spin-off plan stays in focus

Applied Digital shares climbed 4.6% to $25.20 Wednesday afternoon, outperforming a weaker market after Northland and Lake Street reiterated bullish ratings ahead of the Jan. 7 earnings call. The company recently signed a non-binding term sheet to spin out its cloud unit and merge it with EKSO Bionics, forming ChronoScale, a GPU-accelerated cloud platform. Applied Digital expects to own 97% of the new entity.
31 December 2025
··
Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

Corcept Therapeutics (CORT) stock dives nearly 50% after FDA rejects relacorilant — what investors watch next

Corcept shares plunged nearly 50% to $35.31 after the FDA rejected relacorilant for Cushing’s-related hypertension, citing insufficient evidence of effectiveness. The move erased about $3.7 billion in market value. Corcept said it will meet with the FDA to discuss next steps. The company is also awaiting a July 2026 FDA decision on relacorilant in ovarian cancer.
31 December 2025
··
JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

JPMorgan stock edges up in thin year-end trade as Fed minutes and funding markets steer banks

JPMorgan shares rose 0.3% to $324.25 in afternoon trading Wednesday, outperforming major U.S. banks. Treasury yields climbed after weekly jobless claims dropped to 199,000, below forecasts. The Federal Reserve minutes showed officials divided over the 2026 rate outlook. Investors await JPMorgan’s earnings on Jan. 13 and the Fed’s Jan. 27–28 meeting.
31 December 2025
··
IREN stock slips in New York trade as bitcoin eases into year-end

IREN stock slips in New York trade as bitcoin eases into year-end

IREN shares fell about 1% to $37.92 Wednesday afternoon, tracking a 0.6% drop in bitcoin, which traded near $87,688. U.S.-listed bitcoin miners were mixed as year-end portfolio adjustments continued. Marathon Digital and CleanSpark declined, while Riot Platforms gained. IREN traded between $37.58 and $38.98, with 12.7 million shares changing hands by early afternoon.
31 December 2025
·········
Eli Lilly stock today: LLY slips as China Mounjaro cuts and U.S. pricing reset draw focus

Eli Lilly stock today: LLY slips as China Mounjaro cuts and U.S. pricing reset draw focus

Eli Lilly shares slipped 0.1% to $1,078.95 by early afternoon Wednesday after reports of price cuts for its diabetes and obesity drugs in China and a planned U.S. list-price reset. A regulatory filing showed Lilly Endowment, the company’s largest shareholder, trimmed its stake slightly. Investors focused on pricing pressure as the company’s GLP-1 drugs face broader access and lower prices heading into 2026.
31 December 2025
···
1 … 477 478 479 480 481 … 748

Stock Market Today

  • Ipsen Shares Surge With Mixed Valuations: Market vs. Intrinsic Value Debate
    April 24, 2026, 1:03 AM EDT. Ipsen (ENXTPA:IPN) has shown strong share price gains, including a 42.55% year-to-date rise and a 70.55% total return over one year. The stock traded at €165.50, modestly above an analyst-derived fair value of €151.94, suggesting slight overvaluation. Analysts predict a 5.5% annual revenue growth and profit margin expansion through 2026. However, a discounted cash flow (DCF) model estimates intrinsic value at €259.24, implying a 36% undervaluation. This discrepancy raises questions about the stock's true worth amid reliance on a few key drugs and potential regulatory risks. Investors face conflicting narratives and must assess whether market pricing or fundamental valuation better reflects Ipsen's outlook.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 24.04.2026

24 April 2026
Old Republic International closed at $39.90, below its estimated fair value of $42.50. The company is focusing on digitalization and AI to improve efficiency and margins. Risks include volatility in title insurance and weaker real estate activity. Market sentiment is mixed as investors assess growth prospects and challenges.
Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

24 April 2026
Newmont reported adjusted first-quarter earnings of $2.90 per share on $7.31 billion in sales, beating estimates as realized gold prices surged to $4,900 an ounce. Attributable gold output fell to 1.30 million ounces from 1.54 million a year earlier. The miner declared a $0.26 dividend and authorized a new $6 billion share buyback. Newmont expects higher costs and lower output in the second quarter.
SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

24 April 2026
SAP reported a 17% rise in first-quarter operating profit to 2.74 billion euros and a 19% jump in cloud revenue to 5.96 billion euros, beating forecasts. The company kept its 2026 targets and full-year outlook unchanged. SAP’s U.S. shares reversed losses after the results, climbing nearly 7% in after-hours trading. Management warned cloud revenue growth will slow in the second quarter.
Go toTop